Airway Therapeutics secures $50m for Phase IIb/III zelpultide alfa trial
Airway Therapeutics expects to complete an interim analysis of the Phase IIb trial by the end of Q2 2027.
Clinical Trials
Patient enrolment concludes in Senhwa’s Phase Ib trial of pidnarulex
Liminatus Pharma selects Synex to advance CAR-T trial
Enrolment opens for Adaptin Bio’s Phase I trial of glioblastoma therapy
Polyrizon finalises five site agreements for Nasarix trial
UK MHRA grants approval for Scancell’s Phase III study of iSCIB1+
Novo Nordisk commences study for reduced Wegovy pill dosing
Abcuro secures $66m to support clinical trial of ulviprubart for IBM
